Elecampane
AsteraceaeInula helenium
Also known as: Alant, Horseheal, Elfwort
clinical_notes Clinical Summary
Elecampane (Inula helenium) is a cornerstone respiratory herb in Western, Ayurvedic, and Unani traditions, prized for its ability to loosen and expel phlegm, relax bronchial spasm, and soothe inflamed airways.
Its root contains up to 44% inulin (a prebiotic fibre with digestive benefits) and potent sesquiterpene lactones (alantolactone, isoalantolactone) with documented in vitro antimicrobial activity against Staphylococcus aureus including MRSA.
Clinically, it is best suited for chronic, wet productive coughs with mucus congestion, used alongside hydration and supportive care.
Avoid in Asteraceae-allergic patients and during pregnancy; large doses can cause GI irritation.
Pregnancy Safety
Emmenagogue activity and traditional contraindication in pregnancy. Insufficient human clinical data. Avoid during pregnancy due to theoretical uterine stimulant effects; rated C per Mills & Bone.
Lactation Safety
No human lactation data available. Safety has not been established. Conservative approach: avoid medicinal doses during breastfeeding.
warning Contraindications
- Known allergy to Asteraceae (daisy) family plants (contraindicated)Clinically Proven
- Pregnancy (avoid)Theoretical
- Large doses (above therapeutic range) (caution)Clinically Proven
vital_signs Clinical Profile
Primary Indications
- check_circle bronchitis
- check_circle asthma
- check_circle whooping cough
- check_circle respiratory catarrh with excessive mucus
- check_circle chronic productive cough
- check_circle MRSA and staphylococcal infections (adjunctive)
- check_circle intestinal parasites (roundworm, hookworm, threadworm)
- check_circle dyspepsia and digestive debility
- check_circle anorexia
- check_circle poor digestion
Therapeutic Actions
System Affinities
- check_circle respiratory
- check_circle digestive
- check_circle urinary
- check_circle immune
labs Active Constituents
alantolactone
isoalantolactone
igalan
alloalantolactone
dugesialactone
inulin
volatile oils
thymol derivatives
azulene
mucilage
resin
pectin
sesquiterpene lactones
eudesmanolides
history_edu Traditional Use
No TCM data available for this herb yet.
Traditional Uses Across Healing Systems
While many herbs lack controlled clinical trials, centuries of traditional practice across cultures provide valuable insight into their therapeutic applications.
Primary respiratory tonic for bronchitis, asthma, whooping cough, and chronic productive cough; anthelmintic for intestinal parasites; digestive bitter tonic for dyspepsia; wound healing (scabwort use for skin conditions)
One of the most respected lung tonic herbs in European herbalism. Dioscorides and Pliny recommended it for cough, orthopnoea, and digestive complaints. John Gerard highlighted its use for old, stubborn coughs. Ingredient in absinthe.
Related species Inula racemosa (Pushkarmula) used for cardiovascular and respiratory conditions; Inula helenium itself used for respiratory catarrh and warming lung tonic in folk Ayurvedic practice
Inula racemosa (Pushkarmula) is the primary Ayurvedic Inula species for cardiorespiratory use. I. helenium overlaps in action and has been used in folk Ayurvedic practice in North India.
American Indians used root infusions and decoctions for lung diseases, asthma, and as a general tonic; roots used as diuretic and for chest complaints
Introduced to North America by European settlers; subsequently adopted by various North American Indigenous peoples for respiratory and urinary conditions.
Used as a warming expectorant and respiratory tonic (Raasna); anti-inflammatory for joint pain; digestive bitter
Avicenna made no distinction between several Inula species and used elecampane for respiratory and digestive conditions. Alant root features in Unani Tibb formulations.
spa Parts Used
root
- bronchitis
- chronic productive cough
- asthma
- MRSA/staphylococcal infections
- intestinal parasites
- dyspepsia
- respiratory catarrh
Roots and rhizomes harvested in autumn or early winter (2nd or 3rd year plants). Prepared as decoction (simmered 10-15 min), tincture, or capsules. Decoction preserves inulin content better than alcoholic extracts. Start with lower end of dose range and increase if tolerated.
shield Safety
Contraindications — Evidence Basis
Known allergy to Asteraceae (daisy) family plants
Elecampane is an Asteraceae member. Sesquiterpene lactones (alantolactones) may cause contact dermatitis and allergic hypersensitivity in sensitized individuals. Multiple case reports of contact dermatitis exist.
Pregnancy
Emmenagogue properties documented in traditional use. Insufficient safety data in pregnancy. Traditional texts and regulatory monographs recommend avoidance during pregnancy due to emmenagogue and uterine stimulant activity.
Large doses (above therapeutic range)
Large doses of elecampane can cause vomiting, diarrhea, abdominal cramps, and symptoms of paralysis. Alantolactone can irritate mucous membranes at high concentrations.
Toxicity
Excess above therapeutic dose (>4g dried root three times daily)
Vomiting, diarrhea, abdominal cramps, symptoms of paralysis (with very large doses); mucosal irritation
Discontinue use. Symptomatic management for GI upset. Seek medical attention if paralytic symptoms develop.
Adverse Effects
CYP Metabolism
No significant CYP450 interaction data available for Inula helenium at this time. Sesquiterpene lactones are lipophilic and may theoretically interact with CYP3A4-metabolized drugs; no clinical evidence established. Monitor if co-prescribing with narrow therapeutic index CYP3A4 substrates.
swap_horiz Interactions
Warfarin and Anticoagulants
Class: Anticoagulant
Elecampane sesquiterpene lactones have demonstrated modest anti-inflammatory and platelet-modulating activity in preclinical models. While no direct clinical interaction with warfarin has been reported, theoretical pharmacodynamic interaction via platelet function effects exists. Additionally, sesquiterpenes may weakly induce detoxifying enzymes including glutathione S-transferase, which could theoretically affect drug metabolism.
No established clinical interaction exists. Monitor for unusual bleeding if high-dose elecampane extracts are combined with warfarin. Standard herbal preparations at recommended doses are unlikely to cause clinically significant interactions.
Antidiabetic Agents
Class: Antidiabetic
Inulin from elecampane root is a prebiotic fructan that modulates gut microbiota composition and may improve insulin sensitivity. Alantolactone has shown anti-hyperglycemic activity in animal models via alpha-glucosidase inhibition. While documented clinical interactions are lacking, additive hypoglycemia risk with antidiabetic agents is possible.
Monitor blood glucose when elecampane is added to antidiabetic regimens, particularly in patients with well-controlled diabetes. Evidence for clinically significant interactions is limited.
CYP3A4 Substrates
Class: Various
Sesquiterpene lactones from Inula helenium, including alantolactone and isoalantolactone, have been shown to induce phase II detoxifying enzymes (quinone reductase and glutathione S-transferase) via antioxidant response element activation. This induction activity could theoretically alter the metabolism of CYP3A4 substrates and narrow therapeutic index drugs.
No documented clinically significant CYP interactions with elecampane. Exercise caution with narrow therapeutic index drugs at high elecampane doses. The sesquiterpene lactone content of elecampane can cause contact dermatitis and systemic sensitization reactions in susceptible individuals.
Sedatives and CNS Depressants
Class: CNS Depressant
Animal studies with Inula helenium preparations demonstrated antistressor activity via neuroendocrine pathway modulation involving the HPA axis. This adaptogenic-like CNS activity may theoretically potentiate sedative medications. Alantolactone has also demonstrated CNS protective effects in rodent models.
No documented clinical interactions. Exercise caution when combining high-dose elecampane with sedatives or CNS-active medications. Advise patients on standard precautions until more data are available.
Antimicrobial Agents
Class: Antibiotic
Elecampane sesquiterpene lactones (alantolactone, isoalantolactone) demonstrate potent antibacterial activity against both MRSA and MSSA strains including antibiotic-resistant isolates. The antibacterial mechanism involves cell membrane disruption and is distinct from standard antibiotic targets. Combinatorial approaches suggest potential for synergistic activity with conventional antibiotics.
No clinical drug interaction studies exist. Elecampane should not replace prescribed antibiotics for bacterial infections. Combined use with antibiotics has potential for beneficial synergism in antimicrobial resistance, but this requires further clinical investigation before it can be recommended.
hub Combinations
Synergistic pairings can enhance therapeutic outcomes, while knowing suitable substitutes helps when specific herbs are unavailable or contraindicated.
No combination data available yet.
science Studies
From Monographs to Chromatograms: The Antimicrobial Potential of Inula helenium L. (Elecampane) Naturalised in Ireland
In VitroThis study represents the first assessment of antimicrobial sesquiterpene lactones from naturalised Irish elecampane root, evaluating extracts against clinically relevant bacteria. Alantolactone, isoalantolactone, igalan, and related sesquiterpene lactones were identified as the key antibacterial compounds, showing activity particularly against Staphylococcus species. The geographic origin of the plant did not influence anti-bacterial potency or chemical composition. Given the prevalence of MRSA-associated infections and broad-spectrum antibiotic resistance in Irish hospitals, the authors propose these compounds as potential candidates for future staphylococcal infection control strategies.
Inula helenium and Grindelia squarrosa as a source of compounds with anti-inflammatory activity in human neutrophils and cultured human respiratory epithelium
In VitroThis in vitro study screened plants traditionally used for respiratory tract diseases in Europe, identifying Inula helenium root extract and its sesquiterpene lactone alantolactone as potent suppressors of neutrophil-epithelial adhesion and pro-inflammatory cytokine release. Alantolactone significantly inhibited IL-8, TNF-α, and IL-1β release from neutrophils and A549 respiratory epithelium cells, with efficacy comparable to budesonide (a corticosteroid used as positive control). Inhibition of β2 integrin surface expression on neutrophils was identified as a key mechanism limiting respiratory tract inflammation. These findings scientifically justify the traditional use of elecampane for respiratory inflammatory conditions.
medication Dosing
decoction
1.5–4g dried root per dose
3x daily (TID)
Simmer 1–2 tsp (1.5–4g) chopped dried root in 2 cups water for 15–20 minutes. Strain and drink warm. Decoction method preserves inulin and mucilage for digestive and antitussive benefit. Best for chronic respiratory conditions; drink warm to enhance expectorant action. Can be sweetened with honey.
tincture
1:5 (40–60% alcohol): 1–2ml
3x daily (TID)
Tincture of dried root (1:5, 40–60% ethanol). Take diluted in a little warm water. Useful for both acute and chronic respiratory conditions. For children 6–12 years: half adult dose; children under 6: not recommended without professional supervision.
capsule
300–500mg powdered root
3x daily (TID)
Encapsulated root powder. Less common than decoction or tincture. Choose products with confirmed botanical identity (Inula helenium root). Take with a full glass of water to minimise mucosal irritation from volatile oils.
Disclaimer: This information is largely AI-generated and reviewed by human experts at Evara Health. It is intended for educational and clinical reference purposes only and should not replace professional medical advice.
© 2026 Evara Health. All rights reserved.